Open Access · CC BY-NC 3.0
Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence
Research and Reports in Endocrine Disorders · 2014
DOI: 10.2147/rred.s50952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research and Reports in Endocrine Disorders, 2014. Verfasst von José G Jimenez und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jimenez, J. G., & Haft, G. (2014). Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. https://doi.org/10.2147/rred.s50952
Vancouver
Jimenez JG, Haft G. Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence. Research and Reports in Endocrine Disorders. 2014. doi:10.2147/rred.s50952
BibTeX
@article{Jimenez2014,
author = {Jimenez, José G and Haft, Gregory},
title = {Simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence},
journal = {Research and Reports in Endocrine Disorders},
year = {2014},
doi = {10.2147/rred.s50952}
}
EUVIMED